
Misrib A 5mg/50mg Tablet ER
Marketer
Kenriz Care
Salt Composition
Amlodipine (5mg) + Metoprolol Succinate (50mg)
Overview Misrib A 5mg/50mg Tablet ER
CardioDual 5mg/50mg Extended-Release tablets combine two active ingredients to manage hypertension and rapid heartbeats. This medication also treats angina, cardiac arrhythmias, and chronic congestive heart failure. CardioDual can be ingested at any time, with or without food, but consistent daily timing is recommended. Continue treatment as prescribed; discontinuation, even with symptom improvement, is inadvisable as hypertension is often asymptomatic. Lifestyle modifications such as regular physical activity, weight management, and a balanced diet are also beneficial. Strict adherence to your physician's instructions is crucial. Potential side effects include headache, edema, rash, bradycardia, nausea, and depression. Dizziness may occur; avoid driving or activities requiring alertness until its effects are known. Elevated potassium levels are possible; limit potassium-rich foods and supplements. Regular blood pressure, renal function, and electrolyte monitoring may be necessary. Inform your doctor about pre-existing liver or kidney disease before starting treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Complete disclosure of all current medications, particularly those for hypertension or heart conditions, is essential.
Uses of Misrib A 5mg/50mg Tablet ER
Managing elevated blood pressure and alleviating angina pectoris.
Major Benefits of Misrib A 5mg/50mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Misrib A 5mg/50mg Extended-Release tablets. Swallow the tablets whole; do not crush, chew, or break them. While Misrib A 5mg/50mg ER may be administered with or without food, consistent timing is recommended.
Common Side effects of Misrib A 5mg/50mg Tablet ER:
- Nausea
- Slow heart rate
- Abdominal pain
- Dizziness
- Fatigue
- Sleepiness
- Depression
- Ankle swelling
- Constipation
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Palpitations
- Headache
- Vomiting
- Visual disturbance
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Muscle cramp
- Skin rash
How to use Misrib A 5mg/50mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Misrib A 5mg/50mg Extended-Release tablets can be consumed with or without food, though consistent daily timing is recommended.
How Misrib A 5mg/50mg Tablet ER works:
Extended-release Misrib A tablets (5mg/50mg) contain a dual-medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Misrib A 5mg/50mg Tablet ER ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Misrib A 5mg/50mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Misrib A 5mg/50mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Misrib A 5mg/50mg Extended-Release Tablets. These potential side effects include dizziness, headaches, nausea, or fatigue, which can negatively impact concentration and driving safety.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Misrib A 5mg/50mg Extended-Release tablets without any necessary dosage modification.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Misrib A 5mg/50mg extended-release tablets. Dosage modification of Misrib A 5mg/50mg extended-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Misrib A 5mg/50mg Tablet ER :
Should you forget a Misrib A 5mg/50mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Misrib A 5mg/50mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
